Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled tr... by Hills, Robert K, DPhil, Castaigne, Sylvie, Prof, Appelbaum, Frederick R, Prof, Delaunay, Jacques, MD, Petersdorf, Stephen, MD, Othus, Megan, PhD, Estey, Elihu H, Prof, Dombret, Hervé, Prof, Chevret, Sylvie, PhD, Ifrah, Norbert, Prof, Cahn, Jean-Yves, Prof, Récher, Christian, Prof, Chilton, Lucy, PhD, Moorman, Anthony V, Prof, Burnett, Alan K, Prof

Get full text

Arsenic trioxide and all- trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial by Burnett, Alan K, Prof, Russell, Nigel H, Prof, Hills, Robert K, DPhil, Bowen, David, Prof, Kell, Jonathan, MD, Knapper, Steve, DM, Morgan, Yvonne G, PhD, Lok, Jennie, MSc, Grech, Angela, BA, Jones, Gail, MD, Khwaja, Asim, Prof, Friis, Lone, PhD, McMullin, Mary Frances, Prof, Hunter, Ann, MD, Clark, Richard E, Prof, Grimwade, David, Prof

Get full text

Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial by Cortes, Jorge, Prof, Perl, Alexander E, MD, Döhner, Hartmut, Prof, Kantarjian, Hagop, Prof, Martinelli, Giovanni, Prof, Kovacsovics, Tibor, Prof, Rousselot, Philippe, Prof, Steffen, Björn, MD, Dombret, Hervé, Prof, Estey, Elihu, Prof, Strickland, Stephen, MD, Altman, Jessica K, MD, Baldus, Claudia D, Prof, Burnett, Alan, Prof, Krämer, Alwin, Prof, Russell, Nigel, Prof, Shah, Neil P, Prof, Smith, Catherine C, MD, Wang, Eunice S, Prof, Ifrah, Norbert, Prof, Gammon, Guy, MRCP, Trone, Denise, MS, Lazzaretto, Deborah, MS, Levis, Mark, Prof

Get full text